LDL induced association of anionic liposomes with cells and delivery of contents as shown by the increase in potency of liposome dependent drugs

被引:15
作者
Amin, K
Ng, KY
Brown, CS
Bruno, MS
Heath, TD
机构
[1] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA
[2] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Denver, CO 80262 USA
[3] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA
[4] Mova Pharmaceut, Caguas, PR 00726 USA
关键词
liposome; drug delivery system; liposome stability; low-density lipoprotein;
D O I
10.1023/A:1010971808006
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To establish whether anionic liposomes interact with the low-density lipoprotein (LDL) receptor, to determine the role of lipoproteins in this interaction, and whether the association causes functional delivery of encapsulated drugs. Methods, The cell lines used were CV1-P and CHO wild type, both of which express the LDL receptor, and CHOldlA7, which lacks the LDL receptor. Cellular association of encapsulated methotrexate and fluorescein. labeled phosphatidylethanolamine in the lipid bilayer, was measured. Potency of three liposome dependent drugs (N-phosphonacetyl-L-aspartic acid. fluoroorotic acid, and methotrexate-gamma -aspartate) was also measured by growth inhibition. Results, Association of liposomes containing at least 75 mol egg phosphatidylglycerol (ePG)/100 mol phospholipid with cells grown in defined medium supplemented with 1.0 mg/ml LDL was up to 30-fold higher with CV1-P or CHO wild type cells than with CHOldlA7, and 5-fold higher than association in defined medium lacking LDL. The addition of LDL did not yield any elevation of cellular association of distearoylphosphatidylglycerol liposomes. Increased association was paralleled by a corresponding increase in potency of all three liposome dependent drugs tested. Conclusions. ePG liposomes interact with the LDL receptor in an LDL-dependent fashion, and the interaction results in the delivery of contents to cells.
引用
收藏
页码:914 / 921
页数:8
相关论文
共 28 条
[1]   Identification of scavenger receptor SR-BI as a high density lipoprotein receptor [J].
Acton, S ;
Rigotti, A ;
Landschulz, KT ;
Xu, SZ ;
Hobbs, HH ;
Krieger, M .
SCIENCE, 1996, 271 (5248) :518-520
[2]   THERAPY OF LEISHMANIASIS - SUPERIOR EFFICACIES OF LIPOSOME-ENCAPSULATED DRUGS [J].
ALVING, CR ;
STECK, EA ;
CHAPMAN, WL ;
WAITS, VB ;
HENDRICKS, LD ;
SWARTZ, GM ;
HANSON, WL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (06) :2959-2963
[3]  
BARTLETT GR, 1959, J BIOL CHEM, V234, P466
[4]   CRYSTALLINE DIHYDROPTEROYLGLUTAMIC ACID [J].
BLAKLEY, RL .
NATURE, 1960, 188 (4746) :231-232
[5]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[6]  
BURSTEIN M, 1970, J LIPID RES, V11, P583
[7]   SERUM-INDUCED LEAKAGE OF NEGATIVELY CHARGED LIPOSOMES AT NANOMOLAR LIPID CONCENTRATIONS [J].
COMISKEY, SJ ;
HEATH, TD .
BIOCHEMISTRY, 1990, 29 (15) :3626-3631
[8]   TRANSFER AND EXCHANGE OF PHOSPHOLIPID BETWEEN SMALL UNILAMELLAR LIPOSOMES AND RAT PLASMA HIGH-DENSITY LIPOPROTEINS - DEPENDENCE ON CHOLESTEROL CONTENT AND PHOSPHOLIPID-COMPOSITION [J].
DAMEN, J ;
REGTS, J ;
SCHERPHOF, G .
BIOCHIMICA ET BIOPHYSICA ACTA, 1981, 665 (03) :538-545
[9]   LOW-DENSITY-LIPOPROTEIN AS A VEHICLE FOR TARGETING ANTITUMOR COMPOUNDS TO CANCER-CELLS [J].
FIRESTONE, RA .
BIOCONJUGATE CHEMISTRY, 1994, 5 (02) :105-113
[10]   The NH2-terminal region of apolipoprotein B is sufficient for lipoprotein association with glycosaminoglycans [J].
Goldberg, IJ ;
Wagner, WD ;
Pang, L ;
Paka, L ;
Curtiss, LK ;
DeLozier, JA ;
Shelness, GS ;
Young, CSH ;
Pillarisetti, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (52) :35355-35361